ENOUGH
United Kingdom
- Glasgow, Scotland
- 21/08/2023
- Series C
- $43,582,000
ENOUGHs purpose to ‘make protein sustainable’. Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet.
ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is versatile and can be made into alternative/vegan meat, seafood and dairy products. The company will supply ABUNDA as a B2B (business to business) food ingredient to consumer brands and retailers, addressing the need for high scale supply of healthy and sustainable protein to address a rapidly growing market.
The impact of introducing 1 million tonnes of ABUNDA mycoprotein by 2032 is equivalent to replacing 5 million cows, over a 1 billion chickens and reducing more than 5 million tonnes of CO2 emissions.
- Industry Biotechnology Research
- Website https://www.enough-food.com/
- LinkedIn https://www.linkedin.com/company/enough-food/about/
Related People
Jim LairdFounder
United Kingdom -
St. Albans, England
Highly experienced and entrepreneurial Commercial General Manager with a proven record of profit and value creation in a various sectors including FMCG, life science and technology development.
Achieves results in roles including operations, strategy, change management, M&A and P&L management.
Specialties: Managing, building and getting the best out of teams:
• P&L Management - Sales Growth, Profit and Loss Management, Cost Out Management, Complexity reduction, International Sales
• Change Management - Programme Management, Business Integration, Strategic thinking, Strategic finance, Stakeholder management
• Team Development - Leadership skills, Team and culture development, Communication skills, Managing teams across several markets
Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)